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The CB1 cannabinoid receptor, the main target of Δ9-tetrahydrocan-
nabinol (THC), the most prominent psychoactive compound of
marijuana, plays a crucial regulatory role in brain development as
evidenced by the neurodevelopmental consequences of its manip-
ulation in animal models. Likewise, recreational cannabis use during
pregnancy affects brain structure and function of the progeny.
However, the precise neurobiological substrates underlying the con-
sequences of prenatal THC exposure remain unknown. As CB1 sig-
naling is known to modulate long-range corticofugal connectivity,
we analyzed the impact of THC exposure on cortical projection
neuron development. THC administration to pregnant mice in a
restricted time window interfered with subcerebral projection
neuron generation, thereby altering corticospinal connectivity, and
produced long-lasting alterations in the fine motor performance of
the adult offspring. Consequences of THC exposure were reminis-
cent of those elicited by CB1 receptor genetic ablation, and CB1-null
mice were resistant to THC-induced alterations. The identity of em-
bryonic THC neuronal targets was determined by a Cre-mediated,
lineage-specific, CB1 expression-rescue strategy in a CB1-null back-
ground. Early and selective CB1 reexpression in dorsal telencephalic
glutamatergic neurons but not forebrain GABAergic neurons res-
cued the deficits in corticospinal motor neuron development of
CB1-null mice and restored susceptibility to THC-induced motor
alterations. In addition, THC administration induced an increase
in seizure susceptibility that was mediated by its interference with
CB1-dependent regulation of both glutamatergic and GABAergic
neuron development. These findings demonstrate that prenatal ex-
posure to THC has long-lasting deleterious consequences in the
adult offspring solely mediated by its ability to disrupt the neuro-
developmental role of CB1 signaling.
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Recreational cannabis consumption during pregnancy canexert deleterious consequences in the progeny, including
anxiety, depression, psychosis risk, and cognitive and social im-
pairments (1, 2). In the last two decades, important advances in
our understanding of the endocannabinoid system have paved
the way to elucidate the particular neurobiological substrates
responsible for some cannabinoid-induced neurological alter-
ations in adult animals and humans (3). The currently accepted
scenario is that the CB1 cannabinoid receptor (CB1R), the
main target of marijuana-derived cannabinoids, is located
presynaptically and, upon engagement by endocannabinoids
[2-arachidonoylglycerol (2-AG) and anandamide], can act as a
key neuromodulatory and plasticity-tuning signaling platform
at many different mature synapses (4). In fact, CB1R constitutes
one of the most abundant and functionally relevant G protein-
coupled receptors in several regions of the adult mammalian
brain (3, 4).
Manipulation of CB1R function in animal models, either di-
rectly or indirectly, by modulating 2-AG or anandamide levels
through the main endocannabinoid-synthesizing [diacylglycerol
lipase (DAGL) α/β] or degrading enzymes [monoacylglycerol li-
pase (MAGL) and fatty acid amide hydrolase (FAAH)], in-
fluences key processes of forebrain development, including (i)
progenitor cell expansion and neurogenesis, (ii) neuronal and glial
specification, and (iii) axonal pathfinding (5–7). Alterations of
these developmental processes may conceivably underlie the
functional deficits observed in the offspring upon prenatal expo-
sure to THC. A crucial role has been assigned to CB1R in the
development of long-range axonal connectivity by regulating cor-
ticofugal axon navigation and fasciculation (8, 9). In particular,
CB1R is essential for subcerebral projection neuron development,
as it regulates the appropriate balance between the transcription
factors Ctip2 and Satb2 (10), which is responsible for corticospinal
motor neuron (CSMN) specification (11).
In this study, we modeled prenatal cannabis consumption in
mice to identify the particular neurodevelopmental substrates
responsible for cannabinoid-induced functional alterations that
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remain overt in adult animals. Administration of THC was con-
ducted during a restricted embryonic time window, coinciding with
the active period of glutamatergic neuron generation in the tel-
encephalon (11). To unequivocally assess the role of CB1R sig-
naling in THC-induced alterations, we used CB1R-deficient mice,
which were resistant to THC-induced developmental effects. Next,
by using a Cre-mediated, lineage-specific, CB1R expression-rescue
strategy in a CB1R-null background, we were able to selectively
rescue the deficits in CSMN development of CB1R-deficient mice
and, in turn, fully restore the susceptibility to THC-induced motor
alterations in adulthood. We also found that embryonic THC
exposure induced an increase in seizure susceptibility that was
mediated by CB1R present in developing dorsal telencephalic
pyramidal neurons and forebrain GABAergic neurons. Hence,
targeting CB1R with the most prominent marijuana-derived psy-
choactive compound in a particular neuronal population and time
frame during embryonic development can evoke remarkable long-
lasting neurological alterations.
Results
Prenatal THC Exposure Interferes with Cortical Projection Neuron
Development. To investigate the impact of prenatal THC expo-
sure on cortical development and to avoid the confounding
influence that the cannabinoid could exert during very early
gestational stages (12, 13), we administered one daily i.p. injection
of THC or its vehicle to pregnant wild-type mice from E12.5 to
E16.5. To minimize potential CB1R off-targets, a low dose of
THC (3 mg/kg) was used. Of note, maternal and neonate body
weight was unaffected by THC treatment, thus indicating that the
dose used did not induce deleterious effects on general physical
status. As the CB1R is essential for CSMN specification (10), the
effects of embryonic THC exposure on the developing cortex were
first assessed by quantifying the generation of subcerebral projection
neurons. Confocal immunofluorescence analysis of Ets-related
protein 81 (ER81), a bona fide marker of subcerebral projection
neurons (11), was performed in the treated offspring at P20. ER81+
neurons were decreased in THC-exposed animals compared with
their vehicle-treated controls (Fig. 1 A and B). The impact of THC
on CSMN development was also analyzed at the level of cortico-
spinal axon projections. For this purpose, we performed fluorescent
retrograde labeling (Red RetroBeads) from the cervical spinal cord
to unequivocally identify CSMNs (14) (Fig. 1C). Red-labeled so-
mata in deep cortical layer V were shown to express ER81, thus
confirming the validity of ER81 as an appropriate marker of
CSMNs (Fig. 1D). We also found a significant reduction in the
number of labeled CSMN somata in THC-treated mice compared
with their controls, pointing to an alteration of CSMN development
and subcerebral connectivity (Fig. 1 E and F).
Prenatal THC Exposure Induces Long-Lasting Alterations in Skilled
Motor Function and Seizure Susceptibility. To examine the func-
tional consequences of the impaired subcerebral projection neu-
ron development induced by prenatal cannabinoid exposure, we
first used the skilled reaching test, which allows the dissection of
CSMN-dependent motor function as reflected by the ability to
retrieve a pellet of palatable food with a forelimb through a nar-
row slit (15). To rule out potential unspecific developmental al-
terations in the offspring owing to maternal care induced by THC
administration (16), we used CB1
−/− females, devoid of the be-
havioral impact of THC, which were mated with heterozygous
CB1
+/− males. Therefore, we analyzed skilled motor function in
the CB1
+/− and CB1
−/− offspring. CB1
+/−mice have been shown to
exhibit an increased efficacy of agonist-induced G protein-coupled
receptor signaling, which becomes comparable to that of wild-type
CB1
+/+ mice, thus supporting the validity of this experimental
approach (17). THC-exposed CB1
+/− animals showed a significant
impairment in skilled motor function compared with their vehicle-
treated counterparts (Fig. 2A). Remarkably, CB1
−/− mice, which
consistently with our previous report showed an impairment in this
task compared with their vehicle-treated CB1
+/− littermates (10),
did not suffer from any worsening in their skilled motor perfor-
mance upon THC exposure (Fig. 2A). Importantly, neither the
number of trials (Fig. 2B) nor the success in unskilled conditions
was changed among groups, ruling out generalized motivational or
unspecific motor alterations in the observed skilled motor deficits.
Corticospinal function was also assessed with the staircase test,
and again, a decreased performance was evident in THC-exposed
CB1
+/− mice compared with their vehicle-treated controls (Fig.
2C). In addition, CB1
−/− control mice performed worse than their
CB1
+/− littermates, and THC treatment did not significantly worsen
their ability to reach the pellets. Control quantifications of un-
skilled reaching did not show significant differences among
groups (Fig. 2D). Altogether, these data demonstrate the CB1R
dependency of embryonic THC-evoked motor alterations.
Developmental THC administration induces alterations in
synaptic connectivity and plasticity (18, 19), but its long-lasting
functional consequences remain largely unknown. Therefore, we
analyzed whether seizure susceptibility was affected in the adult
offspring of THC-administered pregnant mice by using a penty-
lenetetrazole (PTZ) administration paradigm. Of note, latency to
seizures was significantly decreased in prenatally THC-exposed
CB1
+/− mice compared with their vehicle-treated counterparts
(Fig. 2E; 31.8 ± 1.4 and 37.0 ± 1.3 min, respectively; P < 0.01).
Fig. 1. Embryonic THC exposure impairs subcerebral projection neuron
development. (A) Subcerebral projection neurons in embryonically vehicle-
and THC-administered mice at P15 were stained with an anti-ER81 antibody
(n = 7 and 5, respectively). (B) ER81+ cell number was quantified and re-
ferred to the total cell number (DAPI) per cortical column. (C) CSMNs were
labeled by injecting retrogradelly transported red fluorescent beads (RetroBeads)
in the cervical spinal cord at P10. (D) Representative image showing Retro-
Bead colocalization with the subcerebral projection neuron marker ER81.
(E) Representative images of retrogradelly labeled somata in cortical layer V
at P15. (F) RetroBead-labeled somata per cortical column were quantified in
vehicle- and THC-exposed mice (n = 5 and 4, respectively). *P < 0.05, **P <
0.01 vs. vehicle-treated mice. [Scale bar, (A and E) 200 μm (Insets, 60 μm) and
(D) 10 μm.]
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Consequently, a reduced PTZ cumulative dose was required to
induce generalized seizures in the THC-treated offspring (Fig. 2F;
THC vs. vehicle, 81.3 ± 4.1 and 96.0 ± 3.5 mg/kg, respectively; P <
0.01). This effect of prenatal cannabinoid administration was
reminiscent of the adult CB1
−/− mice phenotype, which displays
increased seizure susceptibility in the kainic acid model (20, 21).
Importantly, we found no further enhancement of PTZ suscepti-
bility in THC-treated CB1
−/− mice with respect to their vehicle-
treated counterparts, thus confirming the CB1R specificity of THC
action (Fig. 2F; THC vs. vehicle, 30.2 ± 0.7 and 30.1 ± 1.0 min,
respectively). Overall, the neuronal and functional analyses of
prenatally THC-administered mice showed a similar phenotype to
CB1R-null mice, thus indicating that embryonic THC exposure
interferes with the neurodevelopmental role of CB1R signaling.
Prenatal THC Exposure Transiently Impairs CB1R Signaling. We next
analyzed the consequences of prenatal THC administration on
CB1R expression. CB1R protein levels, as determined by Western
blot, were significantly down regulated in THC-treated embryonic
brains at E17.5 compared with controls (Fig. 3 A and C). Notably,
at a perinatal stage (P2.5), CB1R levels returned to those of the
vehicle condition (Fig. 3 B and D), indicating that CB1Rs are al-
tered only transiently in our embryonic THC-exposure paradigm.
The presence of functional plasma membrane-exposed CB1R was
next analyzed by the binding of the radioactively labeled CB1R
agonist [3H]CP-55,940. A reduced cannabinoid binding was ob-
served in the brains of THC-treated embryos at E17.5 (Fig. 3 E
and G), and its values recovered to the level of vehicle-treated
animals at P2.5 (Fig. 3 F and H). Overall, these findings support
that embryonic THC administration transiently disrupts appro-
priate CB1R function in the developing brain.
Neuronal Lineage-Specific CB1R Reexpression Selectively Rescues the
Behavioral Traits of Embryonic THC Exposure. To unequivocally de-
termine the neuronal identity of embryonic THC-exposure ac-
tions, we made use of a Cre-mediated, lineage-specific, embryonic
CB1R expression-rescue strategy in a CB1R-null background
(Stop-CB1 mice) (21). The selective expression of CB1R in dorsal
telencephalic glutamatergic neurons (Glu-CB1-RS mice) was
achieved by expressing Cre under the regulatory elements of the
Nex gene (21). In addition, we rescued CB1R expression in fore-
brain GABAergic neurons (GABA-CB1-RS mice) by using the
Dlx5/6-Cre mouse line (20). As a control, a global CB1R expression
Fig. 2. Embryonic THC exposure impairs corticospinal motor function.
(A and B) The skilled pellet-reaching test was evaluated in adult CB1
+/− and
CB1
−/− littermates prenatally exposed to vehicle or THC from E12.5 to E16.5.
The success ratio of pellets retrieved in the skilled paradigm (A) and the total
number of trials performed (B) were quantified [n = 11 and 8 (CB1
+/− vehicle-
and THC-treated mice, respectively); n = 6 and 4 (CB1
−/− vehicle- and THC-
treated mice, respectively)]. (C and D) Mice were subjected to the staircase
pellet-reaching test, and the sum of pellets retrieved from skilled steps (from
four to eight) was compared between vehicle- and THC-administered mice
(C). As a control, the number of pellets reached in unskilled steps 1–3 was
calculated (D) [n = 8 and 12 (CB1
+/− vehicle- and THC-treated mice, re-
spectively); n = 5 and 3 (CB1
−/− vehicle- and THC-treated mice, respectively)].
(E and F) THC- and vehicle-treated CB1
+/− and CB1
−/− mice were subjected to
a PTZ administration paradigm. Latency to tonic-clonic seizure appearance
after the first PTZ injection (E) and the cumulative dose of PTZ required (F)
were calculated [n = 15 and 18 (CB1
+/− vehicle- and THC-treated mice, re-
spectively); n = 13 and 11 (CB1
−/− vehicle- and THC-treated mice, re-
spectively)]. *P < 0.05, **P < 0.01 vs. vehicle-treated CB1
+/− mice.
Fig. 3. Embryonic THC exposure transiently down-regulates CB1Rs. (A–D)
CB1R protein levels were determined by Western blot in brain samples at
E17.5 (A and C) and P2.5 (B and D) after THC or vehicle administration from
E12.5 to E16.5. The optical density of the CB1R band was quantified and
normalized to β-actin [n = 9 and 6 (E17.5 vehicle- and THC-treated brain
samples, respectively); n = 7 and 7 (P2.5 vehicle- and THC-treated brain
samples, respectively)]. (E–H) Radiolabeled CP-55,940 binding was quantified
in coronal brain sections at E17.5 (E and G) and P2.5 (F and H) [n = 4 and 6
(E17.5 vehicle- and THC-treated brains, respectively); n = 8 and 8 (P2.5 vehicle-
and THC-treated brains, respectively)]. **P < 0.01 vs. vehicle-treated mice.
(Scale bar, 2 mm.)
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rescue approach driven by EIIa-Cre (CB1-RS) was also used (21).
Characterization of CB1R expression by immunofluorescence was
performed in the different mouse lines. In a Stop-CB1 mice-only
background, a nonspecific signal was detected, whereas in Glu-
CB1-RS and GABA-CB1-RS animals, CB1R immunoreactivity was
observed with a distinctive pattern of expression (Fig. 4 A–C). Glu-
CB1-RS mice at P2.5 revealed a significant CB1R expression in
descending corticofugal axons, whereas in GABA-CB1-RS mice a
prominent CB1R expression was observed in the immature hip-
pocampal formation (Fig. 4 A, A1–A4). Cortical CB1R expression
at P20 in Glu-CB1-RS mice appeared as scarce immunopositive
puncta, in agreement with the low expression of the receptor in
mature projection neurons (4), whereas most CB1R expression
corresponded to GABAergic neurons (Fig. 4 B, B1–B4). Double
immunofluorescence with VGLUT1 and VGAT, presynaptic
markers of glutamatergic and GABAergic terminals, respectively,
confirmed the selectivity of the CB1R expression-rescue strategy
(Fig. 4C). Thus, in Glu-CB1-RS mice, the small puncta of CB1R
did not colocalize with VGAT immunoreactivity, in agreement
with their presynaptic location in glutamatergic neurons (Fig. 4C).
To assess the reestablishment of the neurobiological substrate
of THC-induced alterations, we quantified the number of ER81-
positive cells in cortical layer V. Remarkably, in vehicle-treated
Glu-CB1-RS mice, the number of deep-layer ER81-positive cells
per cortical column was significantly rescued compared with
Stop-CB1 animals (96.8 ± 6.6 and 71.7 ± 4.9, respectively; P <
0.05), and in concert, Glu-CB1-RS mice gained susceptibility to
THC-induced impairment of subcerebral projection-neuron de-
velopment (73.2 ± 5.5; P < 0.05 vs. vehicle-treated Glu-CB1-
RS mice).
Once the lineage selectivity of the CB1R expression-rescue
strategy at the cellular level was proved, we investigated the
functional impact of embryonic THC exposure in adulthood.
THC or vehicle was administered to pregnant mice coming from
crosses of Stop-CB1 with Nex-Cre (Glu-CB1-RS) or Dlx5/6-Cre
(GABA-CB1-RS) animals, and their respective offspring were
analyzed at an adult age. CB1R reexpression in Glu-CB1-RS
mice, but not in GABA-CB1-RS mice, rescued the skilled motor
deficits of Stop-CB1 mice as assessed by both the skilled-reaching
test (Fig. 5A) and the staircase test (Fig. 5B). Global rescue of
CB1R expression in CB1-RS mice also abolished the skilled
motor deficits observed in Stop-CB1 mice. Overall, CB1R ex-
pression rescue in dorsal telencephalic glutamatergic neurons is
necessary and sufficient to confer THC susceptibility to corti-
cospinal motor function.
Finally, we also analyzed PTZ-induced seizure susceptibility in
the various CB1R expression-rescued mice. Stop-CB1 mice
showed a seizure-prone phenotype that was fully restored when
the CB1R was expressed systemically in CB1-RS mice, whereas
seizure susceptibility was partially restored in both Glu-CB1-RS
and GABA-CB1-RS (Fig. 5 C and D; latency to seizures in THC-
treated mice, Glu-CB1-RS vs. CB1-RS, 34.0 ± 5.0 and 42.7 ± 2.2 min,
respectively, P < 0.05; GABA-CB1-RS vs. CB1-RS, 33.6 ± 2.2
and 42.7 ± 2.2 min, respectively, P < 0.05; cumulative PTZ
dose, Glu-CB1-RS vs. CB1-RS, 90.0 ± 10 and 106.6 ± 5.1 mg/kg,
respectively, P < 0.05; GABA-CB1-RS vs. CB1-RS, 87.2 ±
6.6 mg/kg and 106.6 ± 5.1 mg/kg, respectively, P < 0.01). Notably,
upon THC administration, only CB1-RS mice showed increases
in seizure latency and PTZ cumulative dose, whereas no signifi-
cant differences were found among Stop-CB1, Glu-CB1-RS, and
GABA-CB1-RS mice (Fig. 5 C and D). These findings support the
notion that prenatal CB1R signaling in both glutamatergic and
GABAergic cell lineages is required for the appropriate balance of
neuronal activity.
Discussion
The present study reveals that embryonic THC exposure exerts
long-lasting consequences in the offspring owing to a transient
disruption of CB1R signaling that impedes the adequate tem-
porally and spatially confined function of the receptor in cortical
neuron development. Remarkably, the deleterious consequences
of prenatal THC exposure in the progeny are independent of the
classical neuromodulatory role of CB1R signaling in the adult
brain and emerge exclusively as a consequence of the transient
disruption of physiological CB1R signaling during prenatal de-
velopment, when synaptic neuronal activity is not yet established.
These findings provide previously unidentified preclinical evi-
dence for the risk of cannabis consumption during pregnancy.
Cannabis is, by far, the most commonly consumed illicit drug
during pregnancy in Western countries, and therefore its use
Fig. 4. Characterization of selective CB1R expression rescue in dorsal glu-
tamatergic neurons and forebrain GABAergic neurons. (A) Immunofluores-
cence analysis of CB1R reexpression driven by Nex (Glu-CB1-RS) (A3), Dlx5/6
(GABA-CB1-RS) (A4), or EIIa (CB1-RS) (A2) promoters in Stop-CB1 mice (A1)
was performed in P2.5 coronal brain sections. (B) Cortical CB1R expression
analysis in the same mouse strains was performed at P20 (B1–B4). (C) Double
immunofluorescence was performed with anti-CB1 antibody combined with
anti-VGLUT1 (C1–C4) or anti-VGAT (C1’–C4’) antibodies. Arrowheads point
to the glutamatergic CB1R signal, which is abundant in pyramidal neuron
fibers at P2.5 (A) and to scarce immunopositive puncta corresponding to
glutamatergic (VGLUT1-positive) terminals at P20 (B and C). Arrows point to
the abundant CB1R signal corresponding to GABAergic (VGAT-positive)
neurons within the hippocampal formation at P2.5 (A) and the mature
cortex at P20 (B and C). [Scale bars, (A) 200 μm, (B) 50 μm (Inset, 10 μm), and
(C) 5 μm.]
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constitutes a considerable public health issue (1, 2, 16). Over the
last few decades, longitudinal studies on human cohorts (1, 2), as
well as research using animal models (22), have addressed the
impact of early cannabinoid exposure in adulthood. The majority
of these studies suggest that early cannabinoid exposure sensitizes
the CNS to cognitive impairments, increases the risk of neuro-
psychiatric disorders such as schizophrenia and anxiety, induces
motor alterations, and enhances drug-addiction susceptibility (23–
25). Our findings show that exposure to low doses of THC in a
narrow temporal window during prenatal development negatively
impacts mouse cortical development, and this, in turn, has long-
term functional consequences on the mature offspring. Specifically,
we unequivocally identify the pool of CB1R located on developing
cortical glutamatergic neurons as the sole reason for the deficits in
corticospinal function induced by embryonic THC exposure.
The CB1R plays a pivotal neurodevelopmental role by trans-
ducing information from the endocannabinoid ligands present in
the neurogenic niche into the coordination of the intrinsic de-
velopmental program of developing neurons (6, 26). In agree-
ment, early developmental exposure of chicken embryos to a
THC analog (27) and genetic manipulation of the CB1R-inter-
acting protein CRIP1 (28) have been shown to disrupt the ap-
propriate balance of transcription factors that intrinsically drive
neuronal development. Thus, CB1R signaling refines the mo-
lecular, laminar, and hodological identity of projection neurons
in the pre- and postnatal cerebral cortex (5, 6). The present
findings support that THC can act as a functional suppressor of
CB1R signaling, as restricted exposure to THC interferes with
developmental CB1R function in a transient but functionally
impacting manner. Therefore, prenatal cannabinoid exposure
recapitulates the long-term structural and functional deficits in
corticospinal connectivity previously demonstrated in CB1R-
knockout mice (10). The susceptibility of axonal connectivity to
embryonic CB1R loss of function (present report) may persist at
later developmental stages in critically susceptible areas, as it has
been demonstrated that THC consumption in adolescents can
also result in axonal connectivity deficits (29). Nevertheless, in
another study, daily marijuana consumption did not induce vol-
umetric changes in several brain areas (30).
Our findings are in partial agreement with a previous study
reporting that chronic prenatal THC administration alters neu-
ronal connectivity by disrupting cytoskeletal dynamics in motile
axons. Specifically, prolonged THC administration (E5.5 to
E17.5) was shown to disrupt cannabinoid signaling by interfering
with 2-AG–metabolizing enzymes, MAGL, and DAGL, but did
not induce CB1R desensitization (18). In that study, the functional
consequences of chronic prenatal THC administration on axonal
projections were not determined. Manipulation of endocannabi-
noid levels in perinatal stages by chronic pharmacological in-
hibition of FAAH, the main anandamide-degrading enzyme,
induced depressive and cognitive impairment traits, despite the
fact that no specific neuronal development alterations could be
demonstrated (9). On the other hand, pharmacological inhibition
of MAGL increased 2-AG levels and induced axon fasciculation
alterations by interfering with Slit2/Robo1 signaling, but the
functional consequences of these actions remain unknown (31).
Other studies have also shown that perinatal cannabinoid admin-
istration induces cognitive deficits that can be linked to neuronal
transmission adaptations, particularly plasticity of glutamatergic
neuron activity (19, 25, 32, 33) and aberrant synaptic organization
(18, 34). In humans, prenatal cannabis exposure interferes with
executive function (2) and increases children’s depressive symp-
toms when excluding identified covariate factors such as maternal
tobacco use, education, and child composite IQ (35). Moreover,
prenatal cannabis exposure interferes with prefrontal cortex-me-
diated response inhibition as revealed by functional MRI, which
may reflect delayed cortical maturation (36). Thus, whereas it is
already known that postnatal cannabinoid exposure has negative
consequences on neurological functions in the adult brain (1), this
study unveils long-lasting functional neuronal alterations induced
by restricted prenatal cannabinoid administration that can be un-
equivocally ascribed to specific developing neuronal lineages. No-
tably, our findings reveal a direct impact of THC exposure on the
developing embryo that does not rely on indirect consequences of
maternal programming and that is evident without the requirement
of a second hit, as proposed for cannabis-induced risk of psychosis
(16). In any case, translating the long-term implications of de-
velopmental cannabis exposure into humans requires a very
stringent control of confounding factors (37, 38), and this is more
important when analyzing cognitive and psychiatric traits than
merely determining plastic adaptations of neuronal activity or
drug abuse sensitivity.
In addition to corticospinal motor function alterations, em-
bryonic THC exposure increased seizure susceptibility in adult
mice, even when CB1Rs return to normal levels shortly after
cessation of THC exposure. The neuromodulatory role of CB1R
in the mature brain exerts overall an anticonvulsant action (4). In
addition, great interest has recently emerged in the potential
application of cannabis preparations enriched in cannabidiol for
the management of pediatric epilepsy disorders such as Dravet
and Gaston–Leroux syndromes (39). However, results presented
herein demonstrate that THC interferes with the developmental
role of CB1R signaling and induces a proepileptogenic neural
Fig. 5. Selective CB1R expression rescue restores functional alterations and
reestablishes THC susceptibility in Stop-CB1 mice. (A and B) Skilled motor
activity was assessed by the skilled pellet-reaching (A) and staircase (B) tests
in adult CB1R-rescued mice [n = 15 and 15 (Stop-CB1 vehicle- and THC-treated
mice, respectively); n = 20 and 17 (CB1-RS vehicle- and THC-treated mice,
respectively); n = 9 and 6 (Glu-CB1-RS vehicle- and THC-treated mice, re-
spectively); n = 5 and 7 (GABA-CB1-RS vehicle- and THC-treated mice, re-
spectively)]. (C and D) Seizure susceptibility to subconvulsive doses of PTZ
was determined. Latency to seizures (C) and the cumulative dose of PTZ
required (D) are shown [n = 13 and 19 (Stop-CB1 vehicle- and THC-treated
mice, respectively); n = 18 and 19 (CB1-RS vehicle- and THC-treated mice,
respectively); n = 9 and 5 (Glu-CB1-RS vehicle- and THC-treated mice, re-
spectively); n = 9 and 8 (GABA-CB1-RS vehicle- and THC-treated mice, re-
spectively)]. *P < 0.05, **P < 0.01 vs. corresponding Stop-CB1 mice;
#P < 0.05,
##P < 0.01 vs. corresponding vehicle-treated group.
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circuitry configuration independently of its neuromodulatory
role in the adult brain. Our CB1R expression-rescue experiments
show that the THC-induced increase in PTZ-evoked seizure
susceptibility relies on alterations not only of projection neurons
but also of GABAergic neurons. Further investigations are
required to underscore the potential contribution of these and
perhaps other neuronal lineages targeted by prenatal cannabi-
noid exposure. In any event, our preclinical observations support
that although cannabis preparations can exert anticonvulsive
actions in children and adults, they can also enhance the risk of
seizures by suppressing CB1R signaling in the developing brain,
thus raising a note of caution that might be considered when the
potential therapeutic uses of cannabinoid-based medicines are
defined and regulated for pregnant women.
Materials and Methods
THC Administration. Ultrapure THC (≥99% HPLC; THC Pharm) was adminis-
tered i.p. to pregnant female mice at a final dose of 3 mg/kg for 5 consec-
utive days from E12.5 to E16.5.
Cellular Analyses and Behavioral Determinations. CSMN immunofluorescence
and retrograde labeling analyses were performed at P20. Skilled motor func-
tion (skilled-reaching and staircase) tests were carried out in 2-month-old mice
prenatally exposed to THC or its vehicle. Seizure susceptibility was assessed by
injecting PTZ (22.5 mg/kg) every 10 min until generalized seizures occurred.
CB1R Biochemical Characterization. CB1R levels were analyzed by Western blot as
well as binding of radiolabeled CP-55,940 in E17.5- and P2.5-treated brain samples.
Genetic CB1R Rescue. CB1R expression rescue was performed in Stop-CB1 mice
by using Nex-Cre, Dlx5/6-Cre, and EIIa-Cre–driven recombination (20, 21).
Immunohistological characterization of different CB1R-rescue mice was per-
formed in P2.5 and P20 brain samples. Corticospinal motor function as well as
seizure susceptibility were assessed in THC- and vehicle-treated 2-month-old
CB1R-rescue mice.
Animals. Experimental designs and procedures were approved by the Com-
plutense University Animal Research Committee in accordance with the Eu-
ropeanCommission regulations. All efforts weremade tominimize the number
of animals and their suffering throughout the experiments.
Additional experimental procedures are described in SI Materials and
Methods.
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